The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Does obesity change the effect of aromatase inhibitors (AIs) on estradiol, leptin, insulin, and IGF-1 serum levels in breast cancer patients?
Mehmet Artac
No relevant relationships to disclose
Dudu Askin
No relevant relationships to disclose
Aysel Kiyici
No relevant relationships to disclose
Onder Orhan Eren
No relevant relationships to disclose
Mufide Oncel
No relevant relationships to disclose
Melih Cem Boruban
No relevant relationships to disclose
Hakan Sat Bozcuk
No relevant relationships to disclose